Cartron G, Letestu R, Dartigeas C, Tout M, Mahé B, Gagez A-L, Ferrant E, Guiu B, Villemagne B, Letuan P, Aurran T, Orsini-Piocelle F, Banos A, Feugier P, Leblond V, de Guibert S, Tournilhac O, Dupuis J, Delmer A, Rouillé V, Ternant D, Leprêtre S. Increased rituximab exposure does not improve response and outcome of patients with chronic lymphocytic leukemia after fludarabine, cyclophosphamide, rituximab. A French Innovative Leukemia Organization (FILO) study. Haematologica [Internet]. 2018Jul.31 [cited 2026Nov.11];103(8):e356-e359. Available from: https://haematologica.org/article/view/8569